Cloud-Based Bio Lab Startup Transcriptic Lands $8.5 Million In Series A Funding To Help It Scale

Months after announcing its Y Combinator partnership and moving into a giant new Menlo Park facility, the robot-operated biolab startup Transcriptic has raised $8.5 million in Series A funding.
Data Collective led the round, with participation from IA Ventures, AME Cloud Ventures, Silicon Valley Bank, 500 Startups, MITS Fund, Y Combinator partner Paul Buchheit and several other angel investors.
This brings the total amount of funds to just over $14 million now, giving the cloud-based lab tests startup some room to purchase proprietary equipment and start moving into drug-screening tests.
Currently, Transcriptic is the only cloud-based robotic bio lab in operation. The robotics lab arm of Emerald Therapeutics is a close competitor with a very similar end goal to run science experiments in the cloud. But it is still in the testing phase and not available to the mass public.
Read More
Comments
Post a Comment